Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Biodelivery Sciences International (MM) (BDSIW)

Biodelivery Sciences International (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BDSIW
DateTimeSourceHeadlineSymbolCompany
08/11/200514:44Business WireBDSI Announces Supply Agreement Relating to BEMA(TM) Fentanyl; Agreement with Aveva Drug Delivery Systems a Key Milestone as BDSNASDAQ:BDSIWBiodelivery Sciences International (MM)
01/11/200512:30Business WireBDSI Prepares For Phase III with BEMA(TM) Fentanyl Following Positive Results of Comparative Pharmacokinetic StudyNASDAQ:BDSIWBiodelivery Sciences International (MM)
05/10/200516:13Business WireBDSI Closes Public Offering of 4.4 Million SharesNASDAQ:BDSIWBiodelivery Sciences International (MM)
30/09/200513:04Business WireBDSI Prices Public Offering of 4.4 Million SharesNASDAQ:BDSIWBiodelivery Sciences International (MM)
30/09/200513:00Business WireBDSI Prices Public Offering of 4.4 Million SharesNASDAQ:BDSIWBiodelivery Sciences International (MM)
16/09/200521:30Business WireBDSI Announces Director Resignations; Donald Ferguson and Alan Pearce Resign So That Company Can Comply with Nasdaq IndependenceNASDAQ:BDSIWBiodelivery Sciences International (MM)
20/07/200515:28Business WireBDSI Announces Acceptance of Emezine(R) NDA for Review By FDANASDAQ:BDSIWBiodelivery Sciences International (MM)
18/07/200516:03Business WireBDSI Secures $7 Million Financing Commitment For Development of BEMA(TM) Fentanyl; Funding Targeted for Phase III Trials of CancNASDAQ:BDSIWBiodelivery Sciences International (MM)
03/06/200512:00Business WireBDSI Secures Additional $2.5 Million Financing With Laurus Master FundNASDAQ:BDSIWBiodelivery Sciences International (MM)
02/05/200512:30Business WireBDSI Announces Submission of NDA for Emezine; First Transmucosal Product for the Treatment of Nausea and VomitingNASDAQ:BDSIWBiodelivery Sciences International (MM)
12/11/200421:37PR Newswire (US)BDSI Reports Financial Results for the Third Quarter Ended September 30, 2004NASDAQ:BDSIWBiodelivery Sciences International (MM)
13/04/200417:00PR Newswire (US)BioDelivery Sciences International, Inc. Announces Licensing of Its Topical BioNasal (TM) Amphotericin B for Chronic SinusitisNASDAQ:BDSIW
06/04/200413:00PR Newswire (US)BioDelivery Sciences International, Inc. Reports 2003 ResultsNASDAQ:BDSIWBiodelivery Sciences International (MM)
 Showing the most relevant articles for your search:NASDAQ:BDSIW

Your Recent History

Delayed Upgrade Clock